EVAg

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NS1; clone: 21.1.1.A; immunization antigen: several inactivated AIV isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: Matrix Protein 1; clone: 4.2.1.A; immunization antigen: several inactivated AIV HxN2 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H1(0/1); clone: 12.2.2.A; immunization antigen: several inactivated AIV H1Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; clone: 13.2.7; targeted antigen: H2(0/1); immunization antigen: several inactivated AIV H2Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H5(0/1); clone: 10.2.1; immunization antigen: several inactivated AIV H5N1 isolates

SARS-CoV-2 nucleoprotein polyclonal antiserum raised in rabbit (#14)

anti-Gn or Gc protein of Puumala orthohantavirus, clone 1B12B3, cell culture supernatant, it is a strain-specific antibody and reacts with PUUV V29 Osnabrück

anti-Gn or Gc protein of Puumala orthohantavirus, clone 5F12B2, cell culture supernatant

anti-Gn or Gc protein of Puumala orthohantavirus, clone 3B12C1, cell culture supernatant

anti-Gn protein of Puumala orthohantavirus, clone 1H7C1, cell culture supernatant

anti-Gc protein of Puumala orthohantavirus, clone 2E10A1, cell culture supernatant

Serum obtained from rabbits challenged with MERS-CoV.

Through direct cloning and expression of the variable heavy chains (VHHs) of HCAbs from the bone marrow of MERS-CoV infected dromedaries, MERS-CoV specific VHHs or nanobodies were produced. VHH-83 binds with exceptionally high affinity to the receptor binding domain of the viral spike protein. In vitro, this VHH efficiently blocks virus entry at picomolar concentrations

Serum obtained from dromedary camels immunized with a MVA vaccine expressing the spike protein and challenged with MERS-CoV.

HCAb-83 is a MERS-CoV specific camel/human chimeric heavy chain only antibody (HCAb) - composed of the camel VHH-83 linked to a human Fc domain lacking the CH1 exon Through direct cloning and expression of the variable heavy chains (VHHs) of HCAbs from the bone marrow of MERS-CoV infected dromedaries, MERS-CoV specific VHHs or nanobodies were produced. VHH-83 binds with exceptionally high affinity to the receptor binding domain of the viral spike protein. In vitro, HCAb-83 efficiently blocks virus entry at picomolar concentrations

The antibody was prepared using the DUF3770 domain (553-1287aa of RNA-dependent RNA polymerase (RdRp)) from the E.coli expression system and is a rabbit-derived anti-serum specific for SFTSV RdRp

rabbit polyclonal antiserum against EV71 capsid protein 1 (VP1)

mouse monoclonal antibodies against the nucleocapsid protein (NP) of CCHFV

mouse monoclonal antibodies against the nucleocapsid protein (NP) of CCHFV

The mouse-derived monoclonal antibody 18C8 is specific for SFTSV Gn protein, but cannot neutralize SFTSV.

anti-Zaire ebola VP40 polyconal rabbit sera

rabbit polyclonal antiserum against the nucleoprotein (NP) of CCHFV

The antibody is a rabbit-derived anti-serum specific for SFTSV nucleoprotein (NP), which is encoded by the S segment

The antibody is a rabbit-derived anti-serum specific for SFTSV Glycoprotein Gn

2 sera samples from Myodes glareolus reactive to Puumala virus